Clovis Oncology, Inc.
Pharmaceutical Preparations · 5500 FLATIRON PARKWAY, SUITE 100, BOULDER, CO 80301
官方登記資料
0位追蹤者
2009成立於
關於 Clovis Oncology, Inc.
Clovis Oncology is an American pharmaceutical company which mainly markets products for treatment in oncology. Clovis was founded in 2009 and is headquartered in Boulder, Colorado. The company is a publicly traded company on NASDAQ under the symbol CLVS and is in the NASDAQ Biotechnology Index with several products in its product pipeline. As of December 31, 2017, the company was not profitable and had incurred losses in each year since its inception in April 2009. In December 2022, Clovis Oncology filed for Chapter 11 bankruptcy.
Source: Wikipedia
產業Pharmaceutical Preparations
總部5500 FLATIRON PARKWAY, SUITE 100, BOULDER, CO 80301
成立時間2009
法律形式C Corporation
狀態營運中
專利41 項專利
IMMUNOSTIMULATORY AGENTS IN COMBINATION WITH ANGIOGENESIS INHIBITORSEP4135752A4 · 2024
HIGH DOSAGE STRENGTH TABLETS OF RUCAPARIBCA2955495C · 2023
關鍵數據
法律資訊
| 法定名稱 | Clovis Oncology, Inc. |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1466301在 SEC EDGAR 上查看 ↗ |
| EIN | 90-0475355 |
| 產業代碼(SIC) | 2834 |
| 登記地址 | 5500 FLATIRON PARKWAY, SUITE 100, BOULDER, CO 80301 |
| 狀態 | 營運中 |
來源: SEC EDGAR · 更新於 2026年10月15日
聯絡方式與連結
地點
5500 FLATIRON PARKWAY, SUITE 100, BOULDER, CO 80301
這是你的公司嗎?
免費認領此頁面,即可新增標誌、產品、照片與職缺,並回覆評論。
認領此頁面